Dashwood Lab
Research Areas
The Dashwood Lab integrates epigenetic and immune approaches for precision oncology and cancer prevention. Epigenetic readers, writers, and erasers that reversibly regulate alternative splicing, as well as immune players in the antigen presentation pathway, are of current mechanistic interest. Lab members come from diverse academic backgrounds, including biochemistry, cancer biology, genetics, molecular nutrition, oncology, and pharmacology. Research tools include primary human colon cancers and patient-matched controls, cultured human colon cancer cells and organoids, preclinical models, and mechanistic studies at the molecular level that are translated to human subjects. The work is supported by the NCI Division of Cancer Prevention and the John S. Dunn Foundation.
Announcements
Congratulations to Ahmed Muhsin, who successfully defended his doctorate in Medical Sciences.
For more updates, follow us on X/Twitter or sign up for our lab newsletter.